Model 435-01 Cardifix Implantable Pacing Lead
by Intermedics, Inc. 510(k)
Active
510(k) K854917
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK854917 | Date11 Mar 1986 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Model 435-01 Cardifix Implantable Pacing Lead is a Permanent Pacemaker Electrode, designed for transvenous implantation to deliver electrical stimulation to the heart. It facilitates cardiac pacing by transmitting pacing pulses to the right atrium or ventricle, supporting patients with bradycardia or conduction disorders. Constructed for long-term use, it integrates with implantable pulse generators to restore normal heart rhythms.
This lead is intended for sterile surgical implantation by qualified healthcare professionals in a clinical setting, such as a cardiac catheterization lab or operating room. Supplied as a single-use device, it must be handled under aseptic conditions and stored according to manufacturer instructions prior to use. The device complies with FDA 510(k) clearance (K854917) under the Cardiovascular advisory committee and falls under Device Class III (regulation number 870.3680). No MRI safety information is specified.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the Model 435-01 Cardifix Implantable Pacing Lead, and where is it typically implanted in the body?
The Model 435-01 Cardifix Implantable Pacing Lead is designed to deliver electrical stimulation to the heart for patients with bradycardia or conduction disorders. It is intended for transvenous implantation, meaning it is inserted through a vein and positioned in either the right atrium or right ventricle to restore normal heart rhythms when integrated with an implantable pulse generator.
Is this device intended for single-use or reusable applications, and what handling precautions should be taken during use?
The Model 435-01 is a single-use device and must be handled under aseptic conditions to ensure sterility. It is intended for sterile surgical implantation by qualified healthcare professionals in controlled environments like a cardiac catheterization lab or operating room. Proper storage and handling prior to use are critical to maintain its integrity.
What regulatory pathway was followed for FDA clearance of this device, and what classification does it fall under?
The Model 435-01 received FDA 510(k) clearance under the Cardiovascular advisory committee via a Traditional 510(k) review, with a decision classification of Substantially Equivalent. It is classified as a Device Class III under regulation number 870.3680, indicating it requires stringent oversight due to its role in life-sustaining or life-supporting functions.
Are there any specific storage instructions provided for this device before implantation?
While the provided data does not detail exact storage conditions, the device is sterile and single-use, so it must be stored according to the manufacturer’s instructions (Intermedics, Inc.) to preserve sterility and functionality. This typically includes protection from contamination, extreme temperatures, and physical damage until use in a clinical setting.